Skip to content

Clinical trials

Hypertension trials in Saudi Arabia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Country / region: Saudi Arabia Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20081
20091
20101
20112
20133
20142
20182
20221
20242
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting3
Terminated3
Active, not recruiting1
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Boehringer Ingelheim3
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3
Bayer2
GlaxoSmithKline2
King Abdulaziz University2
King Saud University2
Prince Sattam Bin Abdulaziz University1
Sanofi1
Umm Al-Qura University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension21
Hyperlipidemias2
Obesity2
Renal Insufficiency, Chronic2
Cardiovascular Diseases1
Chronic Disease1
Diabetes Mellitus1
Diabetes Mellitus, Type 21
Diurnal Enuresis1
Dyslipidemias1

Trials

Showing 51 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.